Our profiles of eRNA expression from GR binding sites agree with reports from BEAS-2B epithelial cells stimulated with TNFα and Dexamethasone, and from A549 and U2OS cancer cell lines [94,95]. The gene discussed is NR3C1; the disease is cancer.